BLOOMBERG. GlaxoSmithKline (GSK) want more regulations of electronic cigarettes, since they compete with Glaxo’s Nicorette gum etc, according to e-mails from a company executive.
”Europe should follow the lead of the U.K., which plans to require e-cigarettes to be licensed as medicines much the way other nicotine-replacement therapy products are, wrote Sophie Crousse, the Brussels-based vice president of European public affairs for Glaxo’s consumer health-care division.”